Innovative Vaccine Approaches | EK50


Sessions

INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants iconINO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

Preview Available

INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

Speaker(s):
Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide iconEpitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide

Preview Available

Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain conserved rational immunogenic peptide

Speaker(s):
BCG & Cyclic Dinucleotides join hands in fight against Tuberculosis and Viral Diseases- Novel approach towards developing a low cost PAN Corona vaccine. iconBCG & Cyclic Dinucleotides join hands in fight against Tuberculosis and Viral Diseases- Novel approach towards developing a low cost PAN Corona vaccine.

Preview Available

BCG & Cyclic Dinucleotides join hands in fight against Tuberculosis and Viral Diseases- Novel approach towards developing a low cost PAN Corona vaccine.

Speaker(s):
First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus iconFirst recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus

Preview Available

First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus

Speaker(s):
Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design iconStabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design

Preview Available

Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design

Speaker(s):
Assessing RNA recombination between an alphavirus replicon vector vaccine and wildtype alphaviruses iconAssessing RNA recombination between an alphavirus replicon vector vaccine and wildtype alphaviruses

Preview Available

Assessing RNA recombination between an alphavirus replicon vector vaccine and wildtype alphaviruses

Speaker(s):
Sterilizing Antiviral Immunity Induced by a CD40L-Based Vaccine iconSterilizing Antiviral Immunity Induced by a CD40L-Based Vaccine

Preview Available

Sterilizing Antiviral Immunity Induced by a CD40L-Based Vaccine

Speaker(s):
Using synthetic biology to generate rapidly manufacturable hyper-stable vaccines iconUsing synthetic biology to generate rapidly manufacturable hyper-stable vaccines

Preview Available

Using synthetic biology to generate rapidly manufacturable hyper-stable vaccines

Speaker(s):
Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses. iconVaccine nanoparticles for elicitation of strong cellular and humoral immune responses.

Preview Available

Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses.

Speaker(s):
COVID-19 Pathogen (SARS-Cov-2) Viral Evolution Leading to Increased Infectivity iconCOVID-19 Pathogen (SARS-Cov-2) Viral Evolution Leading to Increased Infectivity

Preview Available

COVID-19 Pathogen (SARS-Cov-2) Viral Evolution Leading to Increased Infectivity

Speaker(s):
  • Sonam Parag, BS, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine